Nancy A. Simonian

Filings by Nancy A. Simonian span 2 companies, the busiest being Syros Pharmaceuticals, Inc. and Seagen Inc. Over a trading history stretching from 14 May 2021 to 2 December 2024, the count stands at 14 filings.

No open-market purchase appears, only 2 sales. The totals exclude 2 filings filed without an amount. Outside the open market, there are 5 share grants and 6 option exercises. 2024 to date brings no purchases and 2 sales.

Most recently, on 4 December 2024, the filings show an open-market sale in Syros Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.